Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3951606014 | Vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (medicinal product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3951607017 | Live attenuated measles, mumps, and rubella vaccine | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3951608010 | Live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens only vaccine product | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (medicinal product) | Count of base of active ingredient | trois | false | Inferred relationship | Some | ||
| Vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (medicinal product) | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
| Vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (medicinal product) | a pour principe actif (attribut) | Antigen of live attenuated Measles morbillivirus (substance) | true | Inferred relationship | Some | 1 | |
| Vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (medicinal product) | a pour principe actif (attribut) | Antigen of live attenuated Mumps orthorubulavirus (substance) | true | Inferred relationship | Some | 2 | |
| Vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (medicinal product) | a pour principe actif (attribut) | Live attenuated Rubella virus antigen | true | Inferred relationship | Some | 3 | |
| Vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (medicinal product) | est un(e) (attribut) | vaccin contenant seulement antigènes du virus de la rougeole, du virus des oreillons et du virus de la rubéole (produit médicinal) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| M-M-R II powder and diluent for solution for injection Merck Canada Inc. (real clinical drug) | est un(e) (attribut) | True | Vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (medicinal product) | Inferred relationship | Some | |
| PRIORIX powder and diluent for solution for injection GlaxoSmithKline Inc. (real clinical drug) | est un(e) (attribut) | True | Vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (medicinal product) | Inferred relationship | Some | |
| Administration of vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure) | substance utilisée (attribut) | True | Vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (medicinal product) | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR